颅骨骨髓来源单核细胞促进慢性创伤性脑损伤神经炎症
慢性创伤性脑损伤(cTBI)患者神经功能长期恶化且老年更重,机制不明。研究整合临床标本、细胞示踪、多组学、转基因动物、过继转移及概念验证随机临床试验,发现cTBI诱导颅骨骨髓(CBM)持续异常髓系生成,炎性单核/巨噬细胞(Mo/Macs)扩增并随衰老加重,迁移入脑驱动慢性神经炎症和神经功能缺损。机制上衰老相关PPARα缺陷致脂代谢障碍,增强H3K4me3介导的炎性染色质状态。非诺贝特激活PPARα可纠正代谢、减少浸润;40例老年cTBI患者随机试验中非诺贝特降低血浆神经丝轻链并改善认知。
要点
- cTBI后颅骨骨髓持续异常髓系生成,炎性Mo/Macs扩增并随衰老加重。
- CBM来源Mo/Macs迁移入脑驱动慢性神经炎症和神经功能缺损。
- 非诺贝特激活PPARα减少炎性浸润,老年cTBI患者认知改善。
核心结论
- CBM来源炎性Mo/Macs可能是cTBI关键炎症驱动因素,非诺贝特是老年cTBI潜在治疗策略。
研究设计与样本
- 研究整合临床标本、细胞示踪策略、多组学分析、转基因动物实验、过继细胞转移及概念验证随机临床试验。
- 概念验证随机临床试验纳入40例老年cTBI患者。
主要发现
- cTBI诱导CBM持续异常髓系生成,炎性Mo/Macs扩增并随衰老加重。
- CBM来源Mo/Macs主动迁移至脑实质,加剧慢性神经炎症并驱动神经功能缺损。
- 年龄相关PPARα缺陷致Mo/Macs脂代谢功能障碍,增强H3K4me3介导的炎性染色质状态调控。
- 非诺贝特激活PPARα纠正Mo/Mac脂代谢,减少炎性Mo/Mac脑内浸润。
- 40例老年cTBI患者中,非诺贝特降低血浆神经丝轻链水平并改善认知功能。
临床怎么用
- 老年cTBI患者可考虑非诺贝特作为潜在治疗选择,但需进一步验证。
- 监测血浆神经丝轻链水平或有助于评估cTBI治疗反应。
局限性
- 概念验证随机临床试验样本量较小(40例老年cTBI患者),需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with chronic traumatic brain injury (cTBI) experience long-term exacerbated neurological decline, which is even more severe in older patients, yet the underlying mechanisms remain unclear. Cranial bone marrow (CBM) has recently been recognized as an adjacent immune surveillance organ of the brain that rapidly responds to acute brain injury. We investigated whether CBM-derived immune cells contribute to chronic neuroinflammation after cTBI by integrating clinical specimens, cell-tracing strategies, multiomics profiling, transgenic animal assays, adoptive cell transfer, and a proof-of-concept randomized clinical trial. We found that cTBI induced persistent aberrant myelopoiesis in the CBM, characterized by expansion of inflammatory monocytes/macrophages (Mo/Macs), which aggravated with aging. These CBM-derived Mo/Macs actively migrated into brain parenchyma, where they fueled chronic neuroinflammation and drove neurological deficits. Mechanistically, age-related peroxisome proliferator-activated receptor α (PPARα) deficiency caused lipid metabolism dysfunction in these Mo/Macs, enhancing H3K4me3-mediated regulation of inflammatory chromatin states and thereby promoting neuroinflammation. Activation of PPARα via fenofibrate rectified Mo/Mac lipid metabolism and reduced inflammatory Mo/Mac infiltration into the brain. In a proof-of-concept randomized clinical trial enrolling 40 older adult patients with cTBI, fenofibrate treatment reduced plasma neurofilament light chain levels and improved cognitive functions. Together, these findings demonstrate that CBM-originated inflammatory Mo/Macs may serve as key inflammatory drivers of cTBI and further show that fenofibrate represents a potential therapeutic strategy for cTBI treatment in older adults.
引用
- Lu Z, Wang C, Gong P, et al. Cranial bone marrow-derived monocytes promote neuroinflammation in chronic traumatic brain injury. Sci Transl Med. 2026. PMID: 42814802. doi:10.1126/scitranslmed.aef5898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。